BioControl Medical announced today that it has reached an important clinical trial milestone, reaching 480 randomized subjects – or 70 percent – of the planned 650 subjects with congestive heart failure in the INOVATE-HF trial of its CardioFit® system, the first medical device designed to treat
congestive הגייה עם משמעויות, מילים נרדפות, הפכים, תרגומים, משפטים ועוד